Navigation Links
Clazosentan May help to Improve Blood Circulation after Brain Hemorrhage due to burst Aneurysm

A study published in the July edition of the Journal of Neurosurgery suggests that Clazosentan can reduce the // number and severity of cases of constriction of blood vessels (called vasospasm) following aneurysmal subarachnoid haemorrhage (SAH).

Normally constriction of blood vessels occurs approx. 5-14 days following a SAH and this leads to strokes and neurological deficits. This can cause not only significant disability but is also a major cause of death.

Patients on the drug also develop fewer cerebral infarcts. Dr Peter Vajkoczy, Neurosurgeon at the Department of Neurosurgery, University Hospital, Mannheim, and the main author of the study comments: "While our understanding of cerebral vasospasm has continued to improve, a solution to this challenge is yet to be found. However, these results are certainly promising and it is important that these findings are assessed and confirmed in a larger population to identify how clazosentan may have an impact in clinical practice."

Dr Neal Kassell, Professor and Co-chairman of the Department of Neurological Surgery at the University of Virginia comments: "It is encouraging to finally, after nearly one-half century of futile investigations, be able to introduce into clinical trials an agent that, based on experimental studies, has a real potential for preventing vasospasm and, based on preliminary clinical studies, appears to be without significant side effects (including hypotension), as well as exhibiting a suggestion of efficacy."

Over a quarter of people die within the first week following an aneurysmal subarachnoid haemorrhage without treatment. Re-bleeding occurs in 50% of the aneurysms within the first six months, and about half of patients die after a rebleed and a further 20% become disabled.

For further info contact: Actelion contact: Alan Archer Global Product Communications manager Actelion Ltd Gewerbestrasse 16 CH-4123 Allschwil Switz erland 41-79-289-8083 http://www.actelion.com
'"/>




Related medicine news :

1. Hypertensive Drug Improves Sexual Dysfunction in Hypertensive Men
2. Steps To Improve Quality Of Plant-Based Drugs
3. Almonds Improve Cholesterol
4. How to Improve Life Expectancy
5. Sage Improves Memory
6. Protein said to Improve Muscle Loss
7. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
8. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
9. Vitamin B12 Supplements Found To Improve Memory
10. A Loving Relationship Found To Improve Heart Health
11. Fish Found To Improve Fetal Growth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/18/2017)... Aliso Viejo, CA (PRWEB) , ... February 18, ... ... styled animating paragraph presets. Use Pixel Film Studios ’ ProParagraph Fashion ... listings, descriptions, and so many other applications. Users can pick and choose ...
(Date:2/17/2017)... Ocala, FL (PRWEB) , ... February 17, 2017 ... ... of software tools that allow for the electronic prescribing of controlled and non-controlled ... , Ninety percent of pharmacies in the United States now accept electronic ...
(Date:2/17/2017)... ... 17, 2017 , ... Qualis Health, one of the nation's ... Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs that ... multiple award categories, highlighting four of the organization’s current programs:, ...
(Date:2/17/2017)... ... 2017 , ... PrideStaff, a national staffing organization, is pleased ... Industry Analysts' 2017 "Staffing 100 North America" list. , Now in its ... the staffing industry over the last twelve months. Industry insiders and observers nominate ...
(Date:2/17/2017)... ... 2017 , ... Dillon Ruxton Insurance, a Florida-based agency offering ... the greater Fort Lauderdale metropolitan region, is embarking on a cooperative food drive ... LifeNet 4 Families has provided a broad range of food provision services to ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... -- DaVita Inc. (NYSE: DVA ) today announced ... Net income attributable to DaVita Inc. for ... million, or $0.80 per share and $880 million, or $4.29 ... to DaVita Inc. for the quarter and year ended December ... million, or $0.98 per share, and $789 million, or $3.85 ...
(Date:2/16/2017)... ST. LOUIS , Feb. 16, 2017  Express Scripts (NASDAQ: ... one of the World,s Most Admired Companies within the Health Care: ... to be named one of the World,s Most Admired Companies," said ... is driven by the commitment and passion of our 26,000 employees ... people we serve." ...
(Date:2/16/2017)... , Feb 16, 2017 Research and Markets ... Diagnostics Market Analysis & Trends - Function, Application, Cancer Type, Technology ... ... Cancer Diagnostics Market is poised to grow at a CAGR of ... by 2025. Some of the prominent trends ...
Breaking Medicine Technology: